Acurx Pharmaceuticals Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Acurx Pharmaceuticals Inc
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company’s segment consists of the development of clinical and preclinical product candidates for the development of the Company’s proprietary new therapies.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Acurx Pharmaceuticals Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Acurx Pharmaceuticals Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Acurx Pharmaceuticals Inc is ACXP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Acurx Pharmaceuticals Inc has its primary listing on NASDAQ (Small cap). You can trade Acurx Pharmaceuticals Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Acurx Pharmaceuticals Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Acurx Pharmaceuticals Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Acurx Pharmaceuticals Inc.